Abstract
Intravenous injection of prostaglandin (PG) E2 (0.01-1.0 mg/kg) induced a dose-dependent increase in the rectal temperature of urethane-anesthetized rats; the maximum change attained was 0.14 +/- 0.08 to 1.38 +/- 0.16 degrees C at 23 to 51 min after injection. The i.v. injection of PGE2 methyl ester (PGE2-Me), a lipophilic derivative of PGE2, resulted in hyperthermia 1.5-fold higher than that by PGE2 injection over the same dose range. The hyperthermia was associated with tachycardia, hypertension, cutaneous vasodilation and a rise in abdominal skin temperature. Using [3H]PGE2 and radioimmunoassay, we showed PGE2 to be transported into the brain immediately (15 sec) after the i.v. injection of the PG; the PGE2 content ranged from 2.3 +/- 0.5 to 102.6 +/- 5.5 ng/g of brain when given at 0.01 to 1.0 mg/kg, which was 0.07 to 0.13% of the administered dose. When [3H]PGE2-Me was used, the radioactivity in the brain at 15 sec after injection was 1.3- to 2.9-fold higher than that after [3H]PGE2 injection. However, 80% or more of PGE2-Me was hydrolyzed rapidly and recovered as PGE2 in the brain within 15 sec post-injection. PGE2-Me disappeared within 5 min. When PGE2 or PGE2-Me administered i.v. was followed in terms of PGE2, it decreased gradually in the brain with a half-life of 9.0 to 9.5 min in both cases, and was almost undetectable (less than 0.7 ng/g of brain) at the time when rectal temperature reached a peak. The maximum change and duration of hyperthermia were correlated closely with the PGE2 content in the brain.(ABSTRACT TRUNCATED AT 250 WORDS)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|